search

Active clinical trials for "Prostatic Hyperplasia"

Results 431-440 of 588

Prostate Artery Embolization (PAE) for Treatment of Benign Prostatic Hyperplasia

Prostatic HyperplasiaBenign Prostatic Hyperplasia (BPH)7 more

The purpose of this project is to evaluate the safety, efficacy, and feasibility of performing prostatic artery embolization (PAE) using endovascular techniques and particle embolics in men suffering from lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).

Unknown status11 enrollment criteria

Ablation Efficacy of Contact Side Firing Fiber in Predefined Settings for Treating BPH

Treatment of Benign Prostatic Hyperplasia

Twenty (20) subjects presenting with a hyperplasia enlarged prostate and candidates for surgery will undergo a single treatment for ablation of the prostate using the study device.Follow up visits are scheduled for the day of release from the hospital and at 1 and 3 months post procedure. The primary objective of this study is to explore Vaporization efficacy and safety when treating PBH (Benign prostatic hyperplasia ) with the contact side firing fiber with recommended settings.

Unknown status18 enrollment criteria

Advanced Benefits of Alpha-blocker Monotherapy on Lower Urinary Tracts Symptoms(LUTS) Patients

Benign Prostate Hyperplasia

The purpose of this study is to evaluate the clinical efficacy of alpha-blocker monotherapy and alpha-blocker + 5-alpha reductase inhibitor combination therapy in benign prostate hyperplasia patients, and suggest guidelines of the combination therapy.

Unknown status22 enrollment criteria

Prostatic Artery Embolization Versus 532 nm Green Light PVP for Catheterized Patients

Benign Prostate HyperplasiaUrinary Retention

The primary objective is to assess whether prostatic artery embolization has a similar efficacy and safety profile as GreenLight PVP in treating patients with urinary retention secondary to benign prostate hyperplasia (BPH). Subjects who consent will be randomized to either the Prostate embolization (PAE) arm or to the GreenLight PVP arm. The primary endpoint of efficacy of the procedure is measured by the ability of the patient to void. The secondary endpoints recorded will include patients' satisfaction measured by International Prostate Symptom Score (IPSS), peak flow rate (Qmax) and post-void residual urine volume (PVR) and prostate specific antigen (PSA) will be measured at 3, 6, and 12 months post treatment. Also, reduction in prostate volume is considered by MRI preoperatively, 3 months and 12 months.

Unknown status17 enrollment criteria

Prostate Embolization for Acute Urinary Retention Study

Prostatic HypertrophyBenign

The purpose of this study is to assess the feasibility and safety of Prostate Artery Embolization (PAE) in patients suffering of Acute Urinary Retention (AUR) in the context Benign Prostatic Hypertrophy (BPH).

Unknown status20 enrollment criteria

Taiwan ACE Beads for Embolization Therapy in Symptomatic Benign Prostatic Hyperplasia

Lower Urinary Tract SymptomBenign Prostatic Hyperplasia (BPH)

In this proposal, the investigators plan to conduct a clinical trial to validate the efficacy and safety of microspheres (T-ACE Beads).

Unknown status30 enrollment criteria

Urodynamic Evaluation of Disobstrucitve Power of Aquablation VS Laser Techniques

Benign Prostatic Hyperplasia (BPH)

in the last decade, lots of attemps have been done to identify new technologies able to reply the efficacy of gold standard technique for treating BPH, but with a better safety profile. The introduction of laser techniques allowed to reduce complication rates. Among these, considerable importance had Holep and PVP. Aquablation is a recent technique for LUTS treatment. It is minimally invasive, robot-assisted and ultrasound-guided to ablate the prostate in targeted way and in "heat-free" way. It works with high pression water jet. However, in literature informations about disobstructive capacity of minimally invasive techniques, evaluated with invasive urodynamic tests, are low. The enrolled subjects will undergo surgical treatment with one of the techniques under study: Aquablation, HoLEP or PVP. Outpatient visits will be performed at 1, 3 and 6 months after the surgical treatment. During the sixth month visit an invasive urodynamic examination will be performed

Unknown status13 enrollment criteria

Prostate Artery Embolization Compared to Holmium Laser Enucleation of the Prostate for Benign Prostatic...

Benign Prostatic Hyperplasia

The purpose of this study is to evaluate improvement of symptoms from benign prostatic hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS) for prostate artery embolization (PAE) with microspheres (Embozene™, 400µm) compared to conventional Holmium laser enucleation of the prostate (HoLEP).

Unknown status12 enrollment criteria

Intermittent Catheterization Versus Trial Without Catheter

Benign Prostatic Hyperplasia

This is a prospective, comparative, multicenter, randomized controlled trial. The aim of this study is to compare the efficacy, safety and quality of life within patients with acute urinary retention managed by the intermittent catheterization compared or indwelling Foley catheter.

Unknown status11 enrollment criteria

The Effectiveness of Saw Palmetto and Sanmiaoshan on Benign Prostatic Hyperplasia in Chinese Patients...

Prostatic HyperplasiaAdrenergic Alpha-Antagonists

The purpose of this study is to assess the effect of saw palmetto and sanmiaoshan, on top of alpha blocker, on urinary flow rate and BPH symptoms in patients with BPH.

Unknown status13 enrollment criteria
1...434445...59

Need Help? Contact our team!


We'll reach out to this number within 24 hrs